P16INK4a and its regulator miR-24 link senescence and chondrocyte terminal differentiation-associated matrix remodeling in osteoarthritis

Didier Philipot, David Guérit, Daniela Platano, Paul Chuchana, Eleonora Olivotto, Francisco Espinoza, Anne Dorandeu, Yves Marie Pers, Jacques Piette, Rosa M. Borzi, Christian Jorgensen, Danièle Noel, Jean Marc Brondello*

*Autor correspondiente de este trabajo

Resultado de la investigación: Contribución a una revistaArtículorevisión exhaustiva

151 Citas (Scopus)

Resumen

Introduction: Recent evidence suggests that tissue accumulation of senescent p16INK4a-positive cells during the life span would be deleterious for tissue functions and could be the consequence of inherent age-associated disorders. Osteoarthritis (OA) is characterized by the accumulation of chondrocytes expressing p16INK4a and markers of the senescence-associated secretory phenotype (SASP), including the matrix remodeling metalloproteases MMP1/MMP13 and pro-inflammatory cytokines interleukin-8 (IL-8) and IL-6. Here, we evaluated the role of p16INK4a in the OA-induced SASP and its regulation by microRNAs (miRs).Methods: We used IL-1-beta-treated primary OA chondrocytes cultured in three-dimensional setting or mesenchymal stem cells differentiated into chondrocyte to follow p16INK4a expression. By transient transfection experiments and the use of knockout mice, we validate p16INK4a function in chondrocytes and its regulation by one miR identified by means of a genome-wide miR-array analysis.Results: p16INK4a is induced upon IL-1-beta treatment and also during in vitro chondrogenesis. In the mouse model, Ink4a locus favors in vivo the proportion of terminally differentiated chondrocytes. When overexpressed in chondrocytes, p16INK4a is sufficient to induce the production of the two matrix remodeling enzymes, MMP1 and MMP13, thus linking senescence with OA pathogenesis and bone development. We identified miR-24 as a negative regulator of p16INK4a. Accordingly, p16INK4a expression increased while miR-24 level was repressed upon IL-1-beta addition, in OA cartilage and during in vitro terminal chondrogenesis.Conclusions: We disclosed herein a new role of the senescence marker p16INK4a and its regulation by miR-24 during OA and terminal chondrogenesis.
Idioma originalInglés
Número de artículoR58
PublicaciónArthritis Research and Therapy
Volumen16
N.º1
DOI
EstadoPublicada - 27 feb. 2014
Publicado de forma externa

Nota bibliográfica

© 2014 Philipot et al.; licensee BioMed Central Ltd.

Palabras clave

  • Animals
  • Arthritis
  • Experimental
  • Blotting
  • Western
  • Cell Aging
  • Cell Differentiation
  • Chondrocytes
  • Chondrogenesis
  • Cyclin-Dependent Kinase Inhibitor p16
  • Enzyme-linked immunosorbent assay
  • Humans
  • Immunohistochemistry
  • Matrix Metalloproteinase 1
  • Matrix Metalloproteinase 13
  • mesenchymal stromal cells
  • Mice
  • Mice, Knockout
  • MicroRNAs
  • Middle Aged
  • Oligonucleotide Array Sequence Analysis
  • Osteoarthritis
  • Real-Time Polymerase Chain Reaction
  • Transfection

Huella

Profundice en los temas de investigación de 'P16INK4a and its regulator miR-24 link senescence and chondrocyte terminal differentiation-associated matrix remodeling in osteoarthritis'. En conjunto forman una huella única.

Citar esto